Sign inJoin waitlistJoin the waitlist

Joyce Liu

, Associate Chief of the · Mass General Brigham

Credentials: · · · ·

History

the · Mass General Brigham
Present
Division of Gynecologic Oncology · Mass General Brigham
Present
Division of Gynecologic Oncology · Mass General Brigham
Present

Dana-Farber Cancer Institute
2005–2007
Internal Medicine
Brigham and Women's Hospital
2002–2005
Harvard Medical School
1998–2002

Research

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
New England Journal of Medicine · 2018 · 2,290 citations
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised,…
The Lancet Oncology · 2017 · 1,423 citations
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 587 citations

Ursula Matulonis
88 papers
Panagiotis Konstantinopoulos
47 papers
Neil Horowitz
23 papers
Ronny Drapkin
22 papers
Alexi Wright
20 papers
Susana Campos
19 papers
Elizabeth Stover
18 papers
Geoffrey Shapiro
18 papers
Kathleen Moore
17 papers
Carolyn Krasner
16 papers
Michelle Hirsch
16 papers
RP
Richard Penson
15 papers

Clinical trials

Azenosertib in Uterine Serous Carcinoma: Biomarker Study
Principal investigator · Recruiting · Phase 2
Joyce Liu, MD
2025–2028
A Study of Adavosertib as Treatment for Uterine Serous Carcinoma
Principal investigator · Completed · Phase 2
AstraZeneca
2020–2023
AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
2018–2027
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
2016–2027